Chemical exposures in the synthetic rubber industry and lymphohematopoietic cancer mortality

Journal of Occupational and Environmental Medicine

Volumn 47, Issue 9, 2005, Pages 916-932

  Graff, John J ^a,b   Sathiakumar, Nalini ^b   Macaluso, Maurizio ^b   Maldonado, George ^c   Matthews, Robert ^b   Delzell, Elizabeth ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; DIMETHYLDITHIOCARBAMIC ACID; RUBBER; STYRENE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER MORTALITY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MAXIMUM LIKELIHOOD METHOD; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OCCUPATIONAL EXPOSURE; RUBBER INDUSTRY;

EID: 24944488158     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000172866.16615.db     Document Type: Article

References (50)

1. IARC. 1,3-Butadiene. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Occupational Exposures to Mists and Vapours From Strong Inorganic Acids; and Other Industrial Chemicals. Lyon, France: WHO, IARC; 1992;237-285.
2. IARC. 1,3-Butadiene. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Re-Evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. Lyon, France: WHO, IARC; 1999;109-225.
3. National Toxicology Program (U.S.), Technical Resources Inc. Annual Report on Carcinogens. Summary. Washington, DC: U.S. Dept. of Health and Human Services.
4. Irons RD, Pyatt DW. Dithiocarbamates as potential confounders in butadiene epidemiology. Carcinogenesis. 1998;19: 539-542.
5. Irons RD, Stillman WS, Pyatt DW, et al. Comparative toxicity of dithiocarbamates and butadiene metabolites in human lymphoid and bone marrow cells. Chem Biol Interact. 2001;135-136:615-625.
6. Macaluso M, Larson R, Delzell E, et al. Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry. Toxicology. 1996;113:190-202.
7. Fajen J. Butadiene and syrene. In: Assessment of Health Hazards. Lyons: IARC Scientific Publications; 1993.
8. IARC. Styrene. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Industrial Chemicals, Lyon, France: WHO, IARC; 1994;223-320.
9. Pfaffli P, Saamanen A. The occupational scene of styrene. IARC Sci Publ. 1993; 15-26.
10. Delzell E, Macaluso M, Sathiakumar N, Matthews R. Leukemia and exposure to 1,3-butadiene, styrene and dimethyldithiocarbamate among workers in the synthetic rubber industry. Chem Biol Interact. 2001;135-136:515-534.
11. Delzell E, Sathiakumar N, Hovinga M, et al. A follow-up study of synthetic rubber workers. Toxicology. 1996;113:182-189.
12. Macaluso M, Larson R, Lynch J, et al. Historical estimation of exposure to 1,3-butadiene, styrene and dimethyldithiocarbamate among synthetic rubber workers. J Occup Environ Hyg. 2004;1:371-390.
13. NCHS, CDC. National Death Index Plus, Supplement to the NDI User's Manual. Washington, DC: US Department of Health and Human Services; 1999.
14. Sathiakumar N, Delzell E, Abdalla O. Using the National Death Index to obtain underlying cause of death codes. J Occup Environ Med. 1998;40:808-813.
15. Breslow NE, Day NE. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ. 1987;1-406.
16. Callas PW, Pastides H, Hosmer DW. Empirical comparisons of proportional hazards, Poisson, and logistic regression modeling of occupational cohort data. Am J Ind Med. 1998;33:33-47.
17. SAS. SAS Institute Inc., SAS7 Technical Report P-243. SAS/STAT7 Software: The GENMOD Procedure, Release 6.09. Cary, MC: SAS Institute Inc; 1993.
18. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995; 6:356-365.
19. Langholz B, Thomas D, Xiang A, Stram D. Latency analysis in epidemiologic studies of occupational exposures: application to the Colorado Plateau uranium miners cohort. Am J Ind Med. 1999;35: 246-256.
20. Marsh GM, Youk AO, Stone RA, et al. OCMAP-PLUS: a program for the comprehensive analysis of occupational cohort data. J Occup Environ Med. 1998; 40:351-362.
21. Monson RR. Analysis of relative survival and proportional mortality. Comput Biomed Res. 1974;7:325-332.
22. Himmelstein MW, Acquavella JF, Recio L, et al. Toxicology and epidemiology of 1,3-butadiene. Crit Rev Toxicol. 1997;27: 1-108.
23. Huff JE, Melnick RL, Solleveld HA, et al. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science. 1985;227:548-549.
24. Melnick RL, Huff JE, Haseman JK, McConnell EE. Chronic toxicity results and ongoing studies of 1,3-butadiene by the National Toxicology Program. Ann N Y Acad Sci. 1988;534:648-662.
25. Melnick RL, Huff J, Chou BJ, Miller RA. Carcinogenicity of 1,3-butadiene in C57BL/6 × C3H F1 mice at low exposure concentrations. Cancer Res. 1990;50: 6592-6599.
26. Melnick RL, Huff J, Miller RA. Toxicology and carcinogenicity of 1,3-butadiene. In: Assessment Of Inhalation Standards: Integration and Extrapolation Using Diverse Data. New York: Springer Verlag; 1989:177-188.
27. Irons RD, Stillman WS, Cloyd MW. Selective activation of endogenous ecotropic retrovirus in hematopoietic tissues of B6C3F1 mice during the preleukemic phase of 1,3-butadiene exposure. Virology. 1987;161:457-462.
28. Irons RD, Smith CN, Stillman WS, et al. Macrocytic-megaloblastic anemia in male NIH Swiss mice following repeated exposure to 1,3-butadiene. Toxicol Appl Pharmacol. 1986;85:450-455.
29. Irons RD, Smith CN, Stillman WS, et al. Macrocytic-megaloblastic anemia in male B6C3F1 mice following chronic exposure to 1,3-butadiene. Toxicol Appl Pharmacol. 1986;83:95-100.
30. Irons RD, Cathro HP, Stillman WS, et al. Susceptibility to 1,3-butadiene-induced leukemogenesis correlates with endogenous ecotropic retroviral background in the mouse. Toxicol Appl Pharmacol. 1989;101:170-176.
31. Owen PE, Glaister JR, Gaunt IF, Pullinger DH. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/ carcinogenicity study in rats. Am Ind Hyg Assoc J. 1987;48:407-413.
32. Cowles SR, Tsai SP, Snyder PJ, Ross CE. Mortality, morbidity, and haematological results from a cohort of long-term workers involved in 1,3-butadiene monomer production. Occup Environ Med. 1994; 51:323-329.
33. Downs TD, Crane MM, Kim KW. Mortality among workers at a butadiene facility. Am J Ind Med. 1987;12:311-329.
34. Divine BJ, Wendt JK, Hartman CM. Cancer mortality among workers at a butadiene production facility. IARC Sci Publ. 1993:345-362.
35. Divine BJ, Hartman CM. Mortality update of butadiene production workers. Toxicology. 1996;113:169-181.
36. Ward EM, Fajen JM, Ruder AM, et al. Mortality study of workers in 1,3-butadiene production units identified from a chemical workers cohort. Environ Health Perspect. 1995;103:598-603.
37. Ward EM, Fajen JM, Ruder AM, et al. Mortality study of workers employed in 1,3-butadiene production units identified from a large chemical workers cohort. Toxicology. 1996;113:157-168.
38. Divine BJ, Hartman CM. A cohort mortality study among workers at a 1,3 butadiene facility. Chem Biol Interact. 2001; 135-136:535-553.
39. Albertini RJ, Sram RJ, Vacek PM, et al. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study. Res Rep Health Eff Inst. 2003;1-141;discussion 143-162.
40. Kolstad HA, Juel K, Olsen J, Lynge E. Exposure to styrene and chronic health effects: mortality and incidence of solid cancers in the Danish reinforced plastics industry. Occup Environ Med. 1995;52: 320-327.
41. Kolstad HA, Lynge E, Olsen J, Breum N. Incidence of lymphohematopoietic malignancies among styrene-exposed workers of the reinforced plastics industry. Scand J Work Environ Health. 1994;20: 272-278.
42. Wong O, Trent LS, Whorton MD. An updated cohort mortality study of workers exposed to styrene in the reinforced plastics and composites industry. Occup Environ Med. 1994;51:386-396.
43. Matanoski G, Elliott E, Tao X, et al. Lymphohematopoietic cancers and butadiene and styrene exposure in synthetic rubber manufacture. Ann N Y Acad Sci. 1997;837:157-169.
44. Melbye M, Trichopoulos D. Non-Hodgkin's lymphomas. In: Adami H, Hunter D, Trichopoulos D. Cancer Epidemiology. New York: Oxford University Press; 2002:535-555.
45. Nicholson WJ, Selikoff IJ, Seidman H. Mortality experience of styrene-polystyrene polymerization workers. Initial findings. Scand J Work Environ Health. 1978;4 Suppl 2:247-252.
46. Hodgson JT, Jones RD. Mortality of styrene production, polymerization and processing workers at a site in northwest England. Scand J Work Environ Health. 1985;11:347-352.
47. Bond GG, Bodner KM, Olsen GW, Cook RR. Mortality among workers engaged in the development or manufacture of styrene-based products-an update. Scand J Work Environ Health. 1992;18:145-154.
48. Kogevinas M, Ferro G, Andersen A, et al. Cancer mortality in a historical cohort study of workers exposed to styrene. Scand J Work Environ Health. 1994;20: 251-261.
49. Kogevinas M, Ferro G, Saracci R, et al. Cancer mortality in an international cohort of workers exposed to styrene. IARC Sci Publ. 1993;289-300.
50. Coggon D. Epidemiological studies of styrene-exposed populations. Crit Rev Toxicol. 1994;24(Suppl):S107-115.